Omega Healthcare Investors (NYSE:OHI) Issues Quarterly Earnings Results, Misses Expectations By $0.20 EPS

Omega Healthcare Investors (NYSE:OHI – Get Free Report) posted its earnings results on Tuesday. The real estate investment trust reported $0.27 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.20), FiscalAI reports. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The business had revenue of $340.55 million during the quarter, compared to analyst estimates of $269.16 million. During the same quarter in the prior year, the business earned $0.79 earnings per share. The firm’s revenue was down 3.0% compared to the same quarter last year.

Omega Healthcare Investors Price Performance

OHI traded up $0.64 on Wednesday, hitting $48.17. The company had a trading volume of 577,169 shares, compared to its average volume of 2,064,443. Omega Healthcare Investors has a 1-year low of $41.53 and a 1-year high of $52.39. The stock has a market cap of $14.60 billion, a price-to-earnings ratio of 17.19, a price-to-earnings-growth ratio of 1.90 and a beta of 0.56. The company’s fifty day moving average price is $46.18 and its 200 day moving average price is $46.63.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Thursday, November 5th will be paid a dividend of $0.68 per share. This represents a $2.72 annualized dividend and a dividend yield of 5.6%. The ex-dividend date is Thursday, November 5th. Omega Healthcare Investors’s dividend payout ratio is 97.14%.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on OHI. Wells Fargo & Company lowered their price objective on shares of Omega Healthcare Investors from $48.00 to $46.00 and set an “equal weight” rating on the stock in a research note on Monday, October 19th. Cantor Fitzgerald increased their price target on Omega Healthcare Investors from $52.00 to $56.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Citigroup upgraded Omega Healthcare Investors from a “buy” rating to an “outperform” rating in a research report on Thursday, October 22nd. Barclays dropped their price objective on Omega Healthcare Investors from $50.00 to $48.00 and set an “underweight” rating on the stock in a research note on Tuesday, October 13th. Finally, Wall Street Zen upgraded Omega Healthcare Investors from a “hold” rating to a “buy” rating in a report on Saturday, October 17th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $49.93.

Get Our Latest Stock Analysis on OHI

More Omega Healthcare Investors News

Here are the key news stories impacting Omega Healthcare Investors this week:

Omega Healthcare Investors Company Profile

(Get Free Report)

Omega Healthcare Investors, Inc is a real estate investment trust focused on the healthcare sector. The company invests in and owns healthcare facilities, with a primary emphasis on skilled nursing and assisted living properties.

Omega generally leases its properties to healthcare operators under long-term agreements, supporting services for seniors and individuals who require post-acute, rehabilitative, or long-term care. Its portfolio has also included other healthcare-related properties, such as continuing care retirement communities and specialty facilities.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega serves healthcare operators across the United States and the United Kingdom.

Further Reading

Earnings History for Omega Healthcare Investors (NYSE:OHI)

Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.